SCHEMBL26415601

SCHEMBL26415601

c1ccc(-c2nc(-c3ccccc3)nc(-c3cccc4oc5cc(-c6ccc(N(c7ccccc7)c7ccc8ccccc8c7)cc6)ccc5c34)n2)cc1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.33
KDM4E B2RXH2 2/20 0.33
TP53 P04637 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
HSD17B10 Q99714 2/20 0.33
MEN1 O00255 1/20 0.33
CYP1A2 P05177 1/20 0.33
KMT2A Q03164 1/20 0.33
MAPT P10636 3/20 0.31
NR1H4 Q96RI1 1/20 0.31
HPGD P15428 1/20 0.30
TSHR P16473 1/20 0.30
NFKB1 P19838 1/20 0.30
MAPK1 P28482 1/20 0.30
NFKB2 Q00653 1/20 0.30
RELA Q04206 1/20 0.30
ATM Q13315 1/20 0.30
TDP1 Q9NUW8 1/20 0.30
L3MBTL1 Q9Y468 1/20 0.30
HSD17B1 P14061 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26415727 0.98 ALDH1A1 (0.36) ALDH1A1KDM4ETP53SMN1; SMN2HSD17B10
SCHEMBL24574966 0.97 ALDH1A1 (0.36) ALDH1A1KDM4ETP53SMN1; SMN2HSD17B10
SCHEMBL26415594 0.96 ALDH1A1 (0.34) ALDH1A1KDM4ETP53SMN1; SMN2HSD17B10
SCHEMBL26415615 0.96 MEN1 (0.32) ALDH1A1KDM4ETP53SMN1; SMN2HSD17B10
SCHEMBL24255681 0.95 MAPT (0.32) ALDH1A1KDM4ETP53SMN1; SMN2HSD17B10
SCHEMBL24255606 0.95 ALDH1A1 (0.36) ALDH1A1KDM4ETP53SMN1; SMN2HSD17B10
SCHEMBL25848751 0.95 ALDH1A1 (0.36) ALDH1A1KDM4ETP53SMN1; SMN2HSD17B10
SCHEMBL26415617 0.95 KDM4E (0.32) ALDH1A1KDM4ETP53SMN1; SMN2HSD17B10
SCHEMBL26778852 0.94 ALDH1A1 (0.34) ALDH1A1KDM4ETP53SMN1; SMN2HSD17B10
SCHEMBL26778825 0.94 ALDH1A1 (0.34) ALDH1A1KDM4ETP53SMN1; SMN2HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230128360-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT EMITTING DEVICE LT MATERIALS CO., LTD. (KR) 2023-04-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230128360-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT EMITTING DEVICE CRY1, ORC3, ODC1 ALDH1A1 27/4885KDM4E 3080/4885TP53 3548/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.